Table 2 Mean plasma fibrinogen levels in patients with endometrial cancer broken down by clinical–pathological and laboratory parameters
Mean (s.d.) plasma fibrinogen levels (mg per 100 ml) | P -value | |
|---|---|---|
FIGO tumour stage a | 0.002 | |
I | 379.7 (99.6) | |
II | 400.4 (87.8) | |
III and IV | 425.8 (114.9) | |
Histological grade a | 0.2 | |
G1 | 385.8 (104.8) | |
G2 | 383.2 (99.3) | |
G3 | 405.6 (100.9) | |
Histological subtype b | 0.03 | |
Endometrioid histology | 386.1 (98.5) | |
Non-endometrioid histology | 429.1 (144.8) | |
Age b | 0.04 | |
⩽67 years | 379.3 (100.3) | |
>67 years | 398.9 (103.8) | |
CA 125 b | 0.02 | |
⩽40 U ml–1 | 399.6 (87.7) | |
>40 U ml–1 | 432.2 (124.8) | |
White blood cells b | 0.002 | |
⩽1 × 1010 μl–1 | 384.2 (97.4) | |
>1 × 1010 μl–1 | 442.7 (129.6) | |
Platelets b | <0.001 | |
⩽450 000 μl–1 | 385.3 (96.9) | |
>450 000 μl–1 | 563.0 (163.04) | |
